TrialBrain : a journal of neurology2019

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.

Peter J Goadsby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.